Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: A prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory‐Head and Neck Module
David I. Rosenthal(The University of Texas MD Anderson Cancer Center), G. Brandon Gunn(The University of Texas MD Anderson Cancer Center), Tito R. Mendoza(The University of Texas MD Anderson Cancer Center), Katherine A. Hutcheson(The University of Texas MD Anderson Cancer Center), Clifton D. Fuller(The University of Texas MD Anderson Cancer Center), Adam S. Garden(The University of Texas MD Anderson Cancer Center), X. Shelley Wang(The University of Texas MD Anderson Cancer Center), William H. Morrison(The University of Texas MD Anderson Cancer Center), Charles Lu(The University of Texas MD Anderson Cancer Center), Charles S. Cleeland(The University of Texas MD Anderson Cancer Center)
Cited by 152
Related Papers
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JNCI Journal of the National Cancer Institute|2014|1.1k
Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JAMA Oncology|2015|1k
The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation
|International Journal of Radiation Oncology*Biology*Physics|1995|458